Minovia Kicks Off Phase I/II Trial of Experimental Pearson Syndrome Treatment
source: pixabay.com

Minovia Kicks Off Phase I/II Trial of Experimental Pearson Syndrome Treatment

According to a publication from Business Wire, the Israeli biotechnology company Minovia Therapeutics recently finished dosing the first participant in a phase I/II clinical study of the Company's experimental mitochondrial…

Continue Reading Minovia Kicks Off Phase I/II Trial of Experimental Pearson Syndrome Treatment
FDA Approves Soliris for Treatment of Neuromyelitis Optica Spectrum Disorder
source: pixabay.com

FDA Approves Soliris for Treatment of Neuromyelitis Optica Spectrum Disorder

According to a publication at Markets Insider, the Food and Drug Administration (FDA) recently approved Soliris (eculizumab) as a treatment for neuromyelitis optica spectrum disorder. The approval marks the first…

Continue Reading FDA Approves Soliris for Treatment of Neuromyelitis Optica Spectrum Disorder

Novel Ideas at Children’s Hospital Colorado Make Life with Eosinophilic Esophagitis Easier

According to a publication from WCAX, care providers at Children's Hospital Colorado are devising new ways to make life with eosinophilic esophagitis easier. One patient, six-year-old Eliana Yelpaala, is already…

Continue Reading Novel Ideas at Children’s Hospital Colorado Make Life with Eosinophilic Esophagitis Easier
Biotech Companies Team Up to Launch MapKure, a New Joint Venture to Develop Small Molecule Anticancer Drug
rawpixel / Pixabay

Biotech Companies Team Up to Launch MapKure, a New Joint Venture to Develop Small Molecule Anticancer Drug

According to a press release from BeiGene, the Company and SpringWorks Therapeutics have launched MapKure, LLC — a new, jointly-operated venture owned by both partners. MapKure was founded to develop…

Continue Reading Biotech Companies Team Up to Launch MapKure, a New Joint Venture to Develop Small Molecule Anticancer Drug
Study Suggests Russian Healthcare Providers May Be Critically Uninformed About Fabry Disease
opsa / Pixabay

Study Suggests Russian Healthcare Providers May Be Critically Uninformed About Fabry Disease

According to a publication from Fabry Disease News, Russian researchers recently screened over five-and-a-half thousand patients for Fabry disease while they continued with prescribed hemodialysis. The researchers' study, published in…

Continue Reading Study Suggests Russian Healthcare Providers May Be Critically Uninformed About Fabry Disease
Family That Lost Newborn to Trisomy 18 Hosting Fundraiser to Give Back to Hospice Center that Supported Them
https://pixabay.com/en/money-coins-donate-moneybox-cash-230265/

Family That Lost Newborn to Trisomy 18 Hosting Fundraiser to Give Back to Hospice Center that Supported Them

According to a publication from the Basingstoke Gazette, a Basingstoke family is raising money for the children's hospice center that supported them through the loss of a child. Jessica and…

Continue Reading Family That Lost Newborn to Trisomy 18 Hosting Fundraiser to Give Back to Hospice Center that Supported Them
Researchers Observe First Cases of Congenital Leptin Deficiency in the Americas
lisichik / Pixabay

Researchers Observe First Cases of Congenital Leptin Deficiency in the Americas

According to a press release from the Texas Biomedical Research Institute (Texas Biomed), researchers from the Institute have identified another new genetic mutation that they believe can cause rare congenital…

Continue Reading Researchers Observe First Cases of Congenital Leptin Deficiency in the Americas
Children’s National Health System Researchers Receive Grants to Develop High-Tech Diagnostic Aids
https://pixabay.com/en/technology-robot-human-hand-2025795/

Children’s National Health System Researchers Receive Grants to Develop High-Tech Diagnostic Aids

According to a press release from the Children's National Health System (a children's hospital in Washington, D.C.), two scientists from the Institution have been selected to receive federal funding grants…

Continue Reading Children’s National Health System Researchers Receive Grants to Develop High-Tech Diagnostic Aids
Scientists Identify Possible Link Between Pancreatic Cancer and Muscle Wasting Condition Cachexia
mohamed_hassan / Pixabay

Scientists Identify Possible Link Between Pancreatic Cancer and Muscle Wasting Condition Cachexia

According to a publication from EurekAlert, researchers from the University of Oklahoma College of Medicine (OUCM) recently published a study in the journal Gastroenterology suggesting how cachexia is triggered in…

Continue Reading Scientists Identify Possible Link Between Pancreatic Cancer and Muscle Wasting Condition Cachexia
Pancreatic Cancer Medication Shows Strong Promise Treating Advanced Biliary Tract Cancers
stevepb / Pixabay

Pancreatic Cancer Medication Shows Strong Promise Treating Advanced Biliary Tract Cancers

According to a publication from the Arizona BioIndustry Association, Dr. Rachna Shroff and a team of researchers from the Arizona Cancer Center are studying the use of nab-paclitaxel (a pancreatic…

Continue Reading Pancreatic Cancer Medication Shows Strong Promise Treating Advanced Biliary Tract Cancers
King’s College Research Suggests Serotonin Levels Could Predict Parkinson’s Years Before Symptoms
Source: Pixabay

King’s College Research Suggests Serotonin Levels Could Predict Parkinson’s Years Before Symptoms

According to a publication from the BBC, researchers with King's College London believe they've identified early biomarkers for Parkinson's disease that could help physicians predict who will be affected up…

Continue Reading King’s College Research Suggests Serotonin Levels Could Predict Parkinson’s Years Before Symptoms
CIRM Awards $12 Million Grant for Clinical Study of Gene Therapy for Cystinosis Patients
Skitterphoto / Pixabay

CIRM Awards $12 Million Grant for Clinical Study of Gene Therapy for Cystinosis Patients

According to a press release from the California Institute for Regenerative Medicine (CIRM), the Institute's governing body has approved a grant of nearly $12 million to University of California, San…

Continue Reading CIRM Awards $12 Million Grant for Clinical Study of Gene Therapy for Cystinosis Patients

Patient Recruitment Completed for Phase 2 Study of Mucopolysaccharidosis VI Drug Candidate

According to a press release from the French biotechnology company Inventiva, the company has completed recruitment for a phase 2 clinical trial evaluating its experimental mucopolysaccharidosis VI drug, odiparcil. About…

Continue Reading Patient Recruitment Completed for Phase 2 Study of Mucopolysaccharidosis VI Drug Candidate
China Approves Mucopolysaccharidosis Type IVA Drug As Part of Accelerated Review Program
source: pixabay.com

China Approves Mucopolysaccharidosis Type IVA Drug As Part of Accelerated Review Program

According to a publication from BioPortfolio, China's National Medical Products Administration (NMPA — similar to the American FDA) recently approved BioMarin's mucopolysaccharidosis type IVA drug Vimizim for use in the…

Continue Reading China Approves Mucopolysaccharidosis Type IVA Drug As Part of Accelerated Review Program
Study Suggests Female Cancer Patients Have Better Outcomes After Treatment, Experience Worse Side Effects
DarkoStojanovic / Pixabay

Study Suggests Female Cancer Patients Have Better Outcomes After Treatment, Experience Worse Side Effects

According to a publication from EurekAlert, a recent study helmed by the Royal Marsden NHS Foundation Trust suggests that female cancer patients tend to live slightly longer following treatment than…

Continue Reading Study Suggests Female Cancer Patients Have Better Outcomes After Treatment, Experience Worse Side Effects

Experimental Hemophilia A Drug Loses Effectiveness Over Time, Efficacy Questionable After 8th Year

According to a publication from Reuters, based on early clinical data, American biotechnology company BioMarin Pharmaceuticals believes that a single injection of its experimental hemophilia A drug could relieve symptoms…

Continue Reading Experimental Hemophilia A Drug Loses Effectiveness Over Time, Efficacy Questionable After 8th Year
ICYMI: Director of FDA’s Center for Drug Evaluation Discusses Accelerated Approval, Benefits of Master Protocols
source: pixabay.com

ICYMI: Director of FDA’s Center for Drug Evaluation Discusses Accelerated Approval, Benefits of Master Protocols

According to a recent publication from BioPharma Dive, Dr. Janet Woodcock sat for an interview at the Biotechnology Innovation Organization's annual conference in Philadelphia earlier this month. Woodcock, the Director…

Continue Reading ICYMI: Director of FDA’s Center for Drug Evaluation Discusses Accelerated Approval, Benefits of Master Protocols